GEO Group (GEO) Reports Q3 FFO of $0.65, Offers Guidance
Get Alerts GEO Hot Sheet
Price: $31.22 --0%
Financial Fact:
Net income attributable to The GEO Group, Inc.: 43.72M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net income attributable to The GEO Group, Inc.: 43.72M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
GEO Group (NYSE: GEO) reported Q3 FFO of $0.65, versus $0.67 reported last year. Revenue for the quarter came in at $557.3 million versus the consensus estimate of $551.53 million.
GUIDANCE:
GEO Group sees Q4 2021 FFO of $0.65-$0.67.
- We have updated our 2021 financial guidance for the fourth quarter and full year 2021. We expect Net Income Attributable to GEO for the fourth quarter 2021 to be between $40 million and $42 million on quarterly revenues of $554 million to $559 million. We expect fourth quarter 2021 Adjusted Net Income to be between $0.37 and $0.39 per diluted share and fourth quarter 2021 AFFO to be between $0.65 and $0.67 per diluted share.
- For the full year 2021, we expect Net Income Attributable to GEO to be in a range of $165.5 million to $168.0 million on full-year 2021 revenues of approximately $2.26 billion. We expect full year 2021 Adjusted Net Income to be in a range of $1.41 to $1.43 per diluted share and full year 2021 AFFO to be in a range of $2.57 to $2.59 per diluted share. We expect full year 2021 Adjusted EBITDA to be in a range of $451.5 million to $455.0 million.
- Consistent with our previously disclosed expectations, our guidance reflects the non-renewal of our contracts with the Federal Bureau of Prisons at the Big Spring Correctional Facility and Flightline Correctional Facility in Texas, when the current contract option periods expire on November 30, 2021.
For earnings history and earnings-related data on GEO Group (GEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share